UK markets open in 7 hours 40 minutes

CureVac N.V. (CVAC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
38.58-1.60 (-3.98%)
At close: 4:00PM EDT
38.64 +0.06 (+0.16%)
After hours: 07:57PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close40.18
Bid38.25 x 3200
Ask38.65 x 900
Day's range38.25 - 39.64
52-week range37.54 - 151.80
Avg. volume686,715
Market cap7.208B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-1.14
Earnings date16 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est69.61
  • PA Media: Money

    CureVac ditches first generation Covid vaccine to focus efforts on variant jab

    The announcement will not affect UK vaccine supply.

  • Motley Fool

    Why CureVac Stock Is Tumbling Today

    What happened Shares of CureVac (NASDAQ: CVAC) were tumbling 7.4% as of 11 a.m. EDT on Tuesday after falling as much as 13% earlier in the morning. The decline came after the company announced it's withdrawing COVID-19 vaccine candidate CVnCoV from the European Medicines Agency's approval process.

  • EQS Group

    CureVac to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Technology

    DGAP-News: CureVac / Key word(s): Strategic Company Decision12.10.2021 / 13:02 The issuer is solely responsible for the content of this announcement.CureVac to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Technology- COVID-19 vaccine efforts to be re-allocated to accelerate the development of second-generation program in collaboration with GSK- First-generation vaccine candidate, CVnCoV, to be withdrawn from regulatory review due to potential overlap with approval timeli